Improved Zenrelia Label Earns FDA Approval
The U.S. Food and Drug Administration has approved a label change on Elanco Animal Health’s Zenrelia, an oral JAK inhibitor for the control of itching and inflammation associated with skin allergies in dogs at least 12 months old. According to Elanco, “The totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling. The label boxed warning continues to advise discontinuation of Zenrelia for at least 28 days to three months prior to vaccination and withholding Zenrelia for at least 28 days after vaccination due to the risk of inadequate immune response to vaccines.”
CityVet Nears Opening of 70th Clinic
The Dallas-based CityVet network will expand to 70 practices with the opening of a clinic in Spring, Texas, on Oct. 6 and another one in Alexandria, Virginia, on Oct. 13. The owner-operator of the suburban Houston practice is Dr. Tiffany Summers. Dr. Bo Choi will lead the metropolitan Washington clinic.
Gallant Stem Cell Therapy Shows Promise
A stem cell therapy developed by Gallant cleared a major milestone with the U.S. Food and Drug Administration’s Center for Veterinary Medicine. The agency agreed that the animal health biotechnology company’s sonruvetcel suspension for injection provides a reasonable expectation of effectiveness, a key requirement in the conditional approval process. The product is a uterine-derived allogeneic mesenchymal stromal cell therapy for cats with refractory feline chronic gingivostomatitis.
News About New World Screwworm
Merck Veterinary Manual has updated its digital content regarding New World screwworm flies, the cause of a zoonotic disease that has appeared in Central America and Mexico, potentially threatening livestock and the human food supply. The parasite, endemic to South America, was previously eradicated from North America. Learn more at bit.ly/4nm7Ja4.
Nutramax Schedules 2026 CE Conference
Nutramax Laboratories Veterinary Sciences will hold its 2026 “A Different Way to CE” event on Sept. 9 to 12 in Orlando, Florida. The conference will take place at the Gaylord Palms Orlando. Half-price registration is available through Oct. 31, 2025, at register.adifferentwaytoce.org/2026.
N.C. Hospital Is AAHA’s Accredited Practice of the Year
The American Animal Hospital Association has selected Harbor Point Animal Hospital in Mooresville, North Carolina, as the organization’s 2025 Accredited Practice of the Year. The honor was presented at AAHA Con ’25.
VetEvolve Promotes Catherine Howell to CEO
Catherine Howell has been named CEO of VetEvolve, a company that provides administrative services to veterinary practices. Howell, who joined VetEvolve in 2024, most recently served as chief operating officer and interim CEO.
Felixvet Receives OK for Oral Antibiotic
Felixvet has received FDA approval of Clindamycin Hydrochloride Tablets, an oral antibiotic approved for use in dogs to treat skin infections, abscesses, dental infections and osteomyelitis caused by susceptible bacterial strains. The tablets are available in 25-, 75- and 150-milligram dosages and are administered every 12 hours.